Life Science VC Longitude Closes in on Fund II

Life science investor Longitude Venture Partners has raised $332 million toward a planned $375 million second fund, according to a securities filing.

5 September 2012•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.